Alexion Pharmaceuticals Inc. (ALXN)
| Sector: | Health Care |
| |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| |
| History |
Portfolio Manager |
Activity |
Share change |
% change to portfolio ▼ |
| Q1 2021 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
30,309 |
0.04 |
| Q2 2020 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 533.98% |
11,315 |
0.03 |
| Q1 2020 |
| ≡ |
First Eagle Investment Management |
Buy |
50,000 |
0.02 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
2,119 |
0.00 |
| Q2 2019 |
| ≡ |
Harry Burn - Sound Shore |
Add 13.99% |
54,600 |
0.43 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 0.25% |
1,100 |
0.01 |
| Q1 2019 |
| ≡ |
Harry Burn - Sound Shore |
Add 14.88% |
50,550 |
0.39 |
| Q3 2018 |
| ≡ |
Harry Burn - Sound Shore |
Add 12.28% |
42,700 |
0.30 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 1.46% |
6,480 |
0.03 |
| Q2 2018 |
| ≡ |
Harry Burn - Sound Shore |
Buy |
347,850 |
2.23 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 5.05% |
21,280 |
0.10 |
| Q2 2017 |
| ≡ |
Daniel Loeb - Third Point |
Buy |
1,250,000 |
1.35 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 25.66% |
92,025 |
0.51 |
| Q1 2017 |
| ≡ |
Bill Miller - Miller Value Partners |
Add 259.74% |
258,990 |
1.63 |
| Q4 2016 |
| ≡ |
Bill Miller - Miller Value Partners |
Buy |
99,710 |
0.65 |
| Q2 2015 |
| ≡ |
Lee Ainslie - Maverick Capital |
Add 18.52% |
250 |
0.00 |
| Q1 2015 |
| ≡ |
Lee Ainslie - Maverick Capital |
Buy |
1,350 |
0.00 |
| Q4 2011 |
| ≡ |
Thomas Russo - Gardner Russo & Quinn |
Buy |
717 |
0.00 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.